A New Vision of Mount Sinai Downtown

Inside CoverSweeping change in the practice of health care is leading to a transformation in the Mount Sinai Health System’s downtown footprint. A planned investment of more than $500 million will create the new “Mount Sinai Downtown,” an expanded and unified network of facilities—stretching from the East River to the Hudson River—that will provide highly skilled emergency care, urgent care, outpatient, inpatient, and ambulatory services to people living and working in New York City below 34th Street. (more…)

Kenneth L. Davis, MD, President and CEO of Mount Sinai, in Forbes: Price Gougers Like Valeant Pharmaceuticals Must Be Tamed

It’s time to unleash the power of free-market economics to resolve a continuing outrage in the generic drug industry. Price gouging by rogue financial operators posing as pharma companies, most notably Valeant Pharmaceuticals and Turing Pharmaceuticals AG, has been possible because they have exploited distortions in supply and demand. The free market can correct those distortions.

Pin It on Pinterest